Skip to main content
Clinical Trials/NCT02432859
NCT02432859
Completed
Not Applicable

The Effect of Electrical Stimulation on the Expression of VEGF, VEGFR-2, HIF and NO in the Diabetic Foot Ulcer

Tarbiat Modarres University1 site in 1 country30 target enrollmentStarted: November 2013Last updated:
ConditionsDiabetic Foot

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Tarbiat Modarres University
Enrollment
30
Locations
1
Primary Endpoint
The wound fluid level of VEGF, VEGFR-2, HIF-1α and NO (pg/ml)

Overview

Brief Summary

The purpose of this study is to determine whether electrical stimulation is effective in the expression of VEGF, VEGFR-2, HIF-1α and NO and healing in diabetic foot ulcer.

Detailed Description

30 type 2 diabetic patients with ischemic foot ulceration were enrolled. Patients were randomly assigned to electrical stimulation (ES, n=15) or sham ES (placebo, n=15) groups. ES group received cathodal direct current for 1 h/day, 3 days/week, for 4 weeks (12 sessions). Wound fluid sample was collected for VEGF, VEGFR-2, HIF-1α and NO measurement in the first and last treatment sessions before and after intervention. Wound surface area (WSA) was measured at 1st, 6th, and 12th session.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
40 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Ischemic diabetic foot ulcer
  • Wagner classification DFU 2
  • 0.5\<ABI\<0.9
  • Mild to moderate diabetic neuropathy

Exclusion Criteria

  • Fracture in a lower limb
  • A severe infection
  • A malignancy
  • Kidney failure
  • Skin diseases
  • Osteomyelitis
  • Pregnancy

Outcomes

Primary Outcomes

The wound fluid level of VEGF, VEGFR-2, HIF-1α and NO (pg/ml)

Time Frame: Change from Baseline in wound fluid level of VEGF, VEGFR-2, HIF-1α and NO at 4 weeks

Secondary Outcomes

  • Wound surface area(cm2)(Change from Baseline in wound surface area at 2 and 4 weeks)

Investigators

Sponsor
Tarbiat Modarres University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

giti torkaman

Professor of physical therapy, Physical therapy department, Faculty of medical sciences, Tarbiat modares univercity

Tarbiat Modarres University

Study Sites (1)

Loading locations...

Similar Trials